search
Back to results

Wound Infections in Breast Cancer Surgery After Preoperative Skin Preparation With Chlorhexidine vs. Povidone-iodine

Primary Purpose

Wound Infection, Breast Neoplasms

Status
Completed
Phase
Phase 4
Locations
Italy
Study Type
Interventional
Intervention
Chlorhexidine
Povidone-Iodine
Sponsored by
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Wound Infection focused on measuring General surgery, Postoperative

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients undergoing breast surgery at the Fondazione IRCCS National Cancer Institute in Milan (Italy), with or without reconstructive surgery / prosthesis or expander insertion
  • Acceptance of the procedures of the protocol
  • Signature of informed consent for the study

Exclusion Criteria:

  • Refusal of the patient
  • Age < 18 years
  • Pregnancy
  • Patients undergoing abdominal DIEP flap reconstruction
  • Allergy to one of the disinfectants;
  • Pre-existing infection in any body site

Sites / Locations

  • Fondazione IRCCS Istituto Nazionale dei Tumori

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Chloraprep

Povidone-iodine

Arm Description

Preoperative skin preparation with chlorhexidine 2% in alcohol 70% solution

Preoperative skin preparation with povidone-iodine 10% solution

Outcomes

Primary Outcome Measures

Incidence of wound infection after surgery (composite outcome)
Overall incidence of surgical site infections after surgery

Secondary Outcome Measures

Incidence of deep surgical site infection after surgery without implant
Overall incidence of surgical site infections after surgery without implant
Incidence of deep surgical site infection after surgery with implant
Overall incidence of surgical site infections after surgery with implant
Risk factors for surgical site infection evaluation
Multivariate analysis of risk factors: presence or absence of implant, previous chemotherapy treatment, previous radiotherapy treatment, American Society Association class > 2, length of surgery > 2 hours, body mass index > 35, diabetes mellitus
Analysis of extra-cost indicators
Record of number of additional hospital admission due to wound infection; Length of hospital stay; Need for additional surgery due to wound infection;Days of additional antibiotic therapy due to wound infection

Full Information

First Posted
June 15, 2015
Last Updated
September 3, 2021
Sponsor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
search

1. Study Identification

Unique Protocol Identification Number
NCT02479347
Brief Title
Wound Infections in Breast Cancer Surgery After Preoperative Skin Preparation With Chlorhexidine vs. Povidone-iodine
Official Title
A Randomized, Blinded, Single Center Study to Assess the Incidence of Surgical Site Infections in Breast Cancer Surgery After Preoperative Skin Preparation With Chlorhexidine 2% in Alcohol 70% (CHLORAPREP ®) Versus 10% Povidone-iodine
Study Type
Interventional

2. Study Status

Record Verification Date
September 2021
Overall Recruitment Status
Completed
Study Start Date
March 2013 (Actual)
Primary Completion Date
September 2016 (Actual)
Study Completion Date
September 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The development of surgical site infections (SSI) in clean-contaminated surgery is regarded as being preventable. Known to be effective in the prevention of surgical site infection are the adequate sterilization of the surgical instruments, asepsis during operation, antibiotic prophylaxis where indicated, and certainly the preparation of the skin at the incision site, since the patient's skin is the principal source of bacterial contamination of the wound. This study aims to investigate the efficacy in prevention of surgical site infection in clean surgery, using two different standardized methods of skin preparation: povidone-iodine 10% aqueous solution from 1.5 liter bulk bottle, versus tinted 2% chlorhexidine in 70% isopropyl alcohol in a single-dose applicator. To reduce the variables involved, a single-center study will enroll a homogeneous population, undergoing breast cancer surgery.
Detailed Description
The development of surgical site infections (SSI) in clean-contaminated surgery is regarded as being preventable. Known to be effective in the prevention of surgical site infection are the adequate sterilization of the surgical instruments, asepsis during operation, antibiotic prophylaxis where indicated, and certainly the preparation of the skin at the incision site, since the patient's skin is the principal source of bacterial contamination of the wound. Products generally used for preoperative preparation of the skin are iodophores (povidone-iodine), and products containing alcohol and/or chlorhexidine. To date, in the literature there are quite a number of case studies, but only few randomized controlled trials (RCTs) that compare different methods of preparation of the skin at the site of surgery. Only recently a major study comparing between 2 modes of skin preparation before surgery has been performed and published, and at least 2 systematic reviews of various methods can be found. At present, the use of chlorhexidine in alcohol is seen to be more effective than povidone-iodine in the prevention of surgical site infection, but the data derived from the available studies are not sufficient to definitely support a change in the daily practice, and quantitative evaluation of pharmaco-economics implications are still missing. This study aims to investigate the efficacy in prevention of surgical site infection in clean surgery, using two different standardized methods of skin preparation: povidone-iodine 10% aqueous solution from 1.5 liter bulk bottle, versus tinted 2% chlorhexidine in 70% isopropyl alcohol in a single-dose applicator. To reduce the variables involved, a single-center study will enroll a homogeneous population, undergoing breast cancer surgery. The patients included in this study will be randomized according to the week in which they will receive surgical treatment. The investigators expect this approach to be easier to manage within this study. The randomly assigned treatment will be weekly communicated to the chief nurse of the operating theatre who will supply the proper disinfectant without any other role in the study. All patients will be scheduled for at least one follow up visit after about 2 weeks after surgery. All patients have access to more follow up visits, if needed, and will be asked to report all kind of wound complications. The wound assessment will be made by persons not aware of the treatment arm the patient was assigned to, and a defined protocol assessment, based on Centers for Disease Control and prevention (CDC) definitions, which provides the following classification: absence of infection; superficial wound infection; deep wound infection. The final follow-up visit during which the patient will be evaluated will be conducted at 30 days (for patients without insertion of prosthesis / expander) and at 180 days (for patients with the insertion of implants / expander).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Wound Infection, Breast Neoplasms
Keywords
General surgery, Postoperative

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
2158 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Chloraprep
Arm Type
Experimental
Arm Description
Preoperative skin preparation with chlorhexidine 2% in alcohol 70% solution
Arm Title
Povidone-iodine
Arm Type
Active Comparator
Arm Description
Preoperative skin preparation with povidone-iodine 10% solution
Intervention Type
Drug
Intervention Name(s)
Chlorhexidine
Other Intervention Name(s)
Chloraprep (Carefusion)
Intervention Description
Preoperative skin preparation with tinted chlorhexidine gluconate 2% in 70% isopropyl alcohol administered with single-dose applicator
Intervention Type
Drug
Intervention Name(s)
Povidone-Iodine
Other Intervention Name(s)
Betadine
Intervention Description
Preoperative skin preparation with povidone-iodine 10% aqueous solution
Primary Outcome Measure Information:
Title
Incidence of wound infection after surgery (composite outcome)
Description
Overall incidence of surgical site infections after surgery
Time Frame
30 days after surgery without breast implant and 180 days after surgery with implant
Secondary Outcome Measure Information:
Title
Incidence of deep surgical site infection after surgery without implant
Description
Overall incidence of surgical site infections after surgery without implant
Time Frame
30 days after surgery
Title
Incidence of deep surgical site infection after surgery with implant
Description
Overall incidence of surgical site infections after surgery with implant
Time Frame
180 days after surgery
Title
Risk factors for surgical site infection evaluation
Description
Multivariate analysis of risk factors: presence or absence of implant, previous chemotherapy treatment, previous radiotherapy treatment, American Society Association class > 2, length of surgery > 2 hours, body mass index > 35, diabetes mellitus
Time Frame
30 and 180 days after surgery
Title
Analysis of extra-cost indicators
Description
Record of number of additional hospital admission due to wound infection; Length of hospital stay; Need for additional surgery due to wound infection;Days of additional antibiotic therapy due to wound infection
Time Frame
180 days after surgery
Other Pre-specified Outcome Measures:
Title
Cost-effective analysis
Description
Cost-effective analysis if one treatment proves significantly superior to the other
Time Frame
180 days after surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients undergoing breast surgery at the Fondazione IRCCS National Cancer Institute in Milan (Italy), with or without reconstructive surgery / prosthesis or expander insertion Acceptance of the procedures of the protocol Signature of informed consent for the study Exclusion Criteria: Refusal of the patient Age < 18 years Pregnancy Patients undergoing abdominal DIEP flap reconstruction Allergy to one of the disinfectants; Pre-existing infection in any body site
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Martin Langer, Prof
Organizational Affiliation
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Official's Role
Study Chair
Facility Information:
Facility Name
Fondazione IRCCS Istituto Nazionale dei Tumori
City
Milan
State/Province
Mi
ZIP/Postal Code
20133
Country
Italy

12. IPD Sharing Statement

Citations:
PubMed Identifier
10219875
Citation
Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1999 Apr;20(4):250-78; quiz 279-80. doi: 10.1086/501620. No abstract available.
Results Reference
background
PubMed Identifier
20054046
Citation
Darouiche RO, Wall MJ Jr, Itani KM, Otterson MF, Webb AL, Carrick MM, Miller HJ, Awad SS, Crosby CT, Mosier MC, Alsharif A, Berger DH. Chlorhexidine-Alcohol versus Povidone-Iodine for Surgical-Site Antisepsis. N Engl J Med. 2010 Jan 7;362(1):18-26. doi: 10.1056/NEJMoa0810988.
Results Reference
background
PubMed Identifier
20969449
Citation
Lee I, Agarwal RK, Lee BY, Fishman NO, Umscheid CA. Systematic review and cost analysis comparing use of chlorhexidine with use of iodine for preoperative skin antisepsis to prevent surgical site infection. Infect Control Hosp Epidemiol. 2010 Dec;31(12):1219-29. doi: 10.1086/657134. Epub 2010 Oct 22.
Results Reference
background
PubMed Identifier
20878942
Citation
Noorani A, Rabey N, Walsh SR, Davies RJ. Systematic review and meta-analysis of preoperative antisepsis with chlorhexidine versus povidone-iodine in clean-contaminated surgery. Br J Surg. 2010 Nov;97(11):1614-20. doi: 10.1002/bjs.7214.
Results Reference
background

Learn more about this trial

Wound Infections in Breast Cancer Surgery After Preoperative Skin Preparation With Chlorhexidine vs. Povidone-iodine

We'll reach out to this number within 24 hrs